Several studies demonstrated that EZH2, a mammalian histone methyltransferase, is emerging as one of the most important targets of miR-101: loss of miR-101 function induces the overexpression of EZH2, which is related to cancer evolution [40,41]. This evidence concerns the gene EZH2 and cancer.